
Alaproclate
CAS No. 60719-82-6
Alaproclate( —— )
Catalog No. M36270 CAS No. 60719-82-6
Alaproclate is a non-competitive NMDA receptor antagonist and a new selective 5-HT uptake inhibitor for the study of depression and dementia.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 445 | Get Quote |
![]() ![]() |
5MG | 686 | Get Quote |
![]() ![]() |
10MG | 938 | Get Quote |
![]() ![]() |
25MG | 1398 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAlaproclate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlaproclate is a non-competitive NMDA receptor antagonist and a new selective 5-HT uptake inhibitor for the study of depression and dementia.
-
DescriptionAlaproclate is a non-competitive NMDA receptor antagonist and a new selective 5-HT uptake inhibitor for the study of depression and dementia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNMDAR
-
RecptorNMDAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number60719-82-6
-
Formula Weight255.74
-
Molecular FormulaC13H18ClNO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC(C)(C)CC1=CC=C(Cl)C=C1)C(N)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Ro 25-6981 Maleate
Ro 25-6981 Maleate is a potent and selective activity-dependent NMDA receptor blocker, specifically targeting the NR2B subunit (IC50 values are 0.009 μM for NR1C/NR2B and 52 μM for NR1C/NR2A receptor subunit combinations).
-
DL-AP5
DL-AP5 is the racemic version of the selective N-methyl-D-aspartate (NMDA) receptor antagonist,with anticonvulsant.DL-AP5, a competitive NMDAR antagonist, on tramadol state-dependent memory.?A single-trial step-down passive avoidance task was used for the assessment of memory retrieval in adult male NMRI mice.?
-
Delucemine Hydrochlo...
Delucemine Hydrochloride (Delucemine) is a polyamine NMDA receptor antagonist used in the study of neurological disorders such as depression and Alzheimer's disease.